Araştırma Makalesi

Effects of open adductor tenotomy and adductor muscle botulinum toxin A injection on the hip instability in spastic type cerebral palsy

Cilt: 47 Sayı: 2 30 Haziran 2022
PDF İndir
EN TR

Effects of open adductor tenotomy and adductor muscle botulinum toxin A injection on the hip instability in spastic type cerebral palsy

Abstract

Purpose: We aimed to evaluate the clinical and radiographic outcomes of hip instability in children with spastic-type Cerebral Palsy (CP) who had undergone open Adductor Tenotomy (AT) or received Botulinum Toxin-A (BTX-A) injections to the hip adductor muscles . Materials and Methods: Maximum Hip Abduction Angles (MHAA) with the knees and hips in extension were measured preoperatively and the latest clinical findings of all patients in the AT and BTX-A groups were recorded. Reimers’ Migration Percentage (RMP) was measured as the radiographic assessment in the AT group. Results: There were 30 patients (mean age: 8.3 years) in the AT Group and 25 (mean age: 5.9 years) in the BTX-A Group whose clinical and radiographic data were available. The mean follow-up period in the AT Group was 29.6 months. In the AT Group, the mean MHAA before surgery and at the last assessment were 21.20 and 37.10 respectively. In the BTX-A Group, the mean MHAA before the injection and at the latest assessment were 25.30 and 34.20 respectively. The change in the mean MHAA in the AT Group was 16.20 and 8.80 in the BTX-A Group. In the AT Group, the preoperative RMP was 28.2% and the latest RMP was 22.2%. Conclusion: AT and BTX-A injections significantly improved hip abduction angles. However, AT provided better clinical improvement and considerable radiographic correction in pediatric patients with spastic-type CP and hip instability.

Keywords

cerebral palsy , botulinum toxin-A , adductor tenotomy

Kaynakça

  1. 1. Novak I, Hines M, Goldsmith S, Barclay R. Clinical prognostic messages from a systematic review on cerebral palsy. Pediatrics. 2012;130:1285-1312.
  2. 2. Yildiz C, Demirkale I. Hip problems in cerebral palsy: Screening, diagnosis and treatment. Curr Opin Pediatr. 2014;26:85-92.
  3. 3. Spiegel DA, Flynn JM. Evaluation and treatment of hip dysplasia in cerebral palsy. Orthop Clin North Am. 2006;37:185-96.
  4. 4. Robin J, Graham HK, Selber P, Dobson F, Smith K, Baker R. Proximal femoral geometry in cerebral palsy: A population-based cross-sectional study. J Bone and Joint Surg Br. 2008;90:1372-9.
  5. 5. Soo B, Howard JJ, Boyd RN, Reid SM, Lanigan A, Wolfe R et al. Hip displacement in cerebral palsy. J Bone and Joint Surg. 2006;88(1):121-9.
  6. 6. Dobson F, Boyd RN, Parrott J, Nattrass GR, Graham HK. Hip surveillance in children with cerebral palsy. Impact on the surgical management of spastic hip disease. J Bone Joint Surg Br. 2002;84:720-6.
  7. 7. Piasek R, Snela S, Rydzak B. Effectiveness of two methods of treatment of the spastic hip in CP children. Ortop Traumatol Rehabil. 2011;13:185-9.
  8. 8. Flynn JM, Miller F. Management of hip disorders in patients with cerebral palsy. J Am Acad Orthop Surg. 2002;10:198-209.
  9. 9. Pap K, Kiss S, Vízkelety T, Szoke G. Open adductor tenotomy in the prevention of hip subluxation in cerebral palsy. Int Orthop. 2005;29:18-20.
  10. 10. Terjesen T, Lie GD, Hyldmo AA, Knaus A. Adductor tenotomy in spastic cerebral Palsy. A long-term follow-up study of 78 patients. Acta Orthop. 2005;76:128-37.

Kaynak Göster

MLA
Asfuroğlu, Zeynel Mert, vd. “Effects of open adductor tenotomy and adductor muscle botulinum toxin A injection on the hip instability in spastic type cerebral palsy”. Cukurova Medical Journal, c. 47, sy 2, Haziran 2022, ss. 511-8, doi:10.17826/cumj.1002995.